Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Shire    SHP   JE00B2QKY057

SHIRE

(SHP)
 SummaryQuotesChartsNewsCalendarCompany 
Company
Shire specializes in developing, producing, and marketing pharmaceutical products for the treatment of nervous system dysfunctions (hyperactivity, epilepsy, Alzheimer's disease, etc.), cancer, gastro-intestinal illnesses, and infectious diseases. Net sales break down by source of income as... 
Sector
Pharmaceuticals
Calendar
-
More about the company
Latest news on SHIRE
05/16TAKEDA PHARMACEUTICAL : Bracing for 383-B.-Yen Net Loss for FY 2019
AQ
05/14TAKEDA PHARMACEUTICAL : expects net loss in FY 2019 due to Shire buyout cost
AQ
04/26TAKEDA PHARMACEUTICAL : Revised Forecast of Consolidated Financials for FY2018
AQ
02/18TAKEDA PHARMACEUTICAL : Notice Regarding Issue of Hybrid Bonds to replace Senior..
AQ
02/15SHIRE : Annual results
CO
02/08Kamada Announces Additional Interim Results from Phase 2 Proof of Concept Cli..
AQ
01/18Alder BioPharmaceuticals Appoints Paul Streck, M.D. Chief Medical Officer
AQ
01/18Alder BioPharmaceuticals Appoints Paul Streck, M.D. Chief Medical Officer
AQ
01/14TAKEDA PHARMACEUTICAL : Shire and SAIIDAC announce planned delisting of notes fr..
AQ
01/11SHIRE PLC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
More news
Analyst Recommendations on SHIRE
More recommendations
Sector news : Pharmaceuticals - NEC
09/17ALEXION PHARMACEUTICALS : Names New Finance Chief
DJ
09/17ABBVIE : Form 8.3 - Allergan Plc
DJ
09/17BAYER : Invests $20 Million in U.S.-Based Informed Data Systems
DJ
09/17Merck Gets FDA Priority Review for Investigational Ebola Zaire Virus Vaccine
DJ
09/17Trial of Tepco executives over Japan's Fukushima disaster heads to conclusion
RE
More sector news : Pharmaceuticals - NEC
Chart SHIRE
Duration : Period :
Shire Technical Analysis Chart | MarketScreener
Full-screen chart
Managers
NameTitle
Howard Mayer Chief Medical Officer
Matthew Walker Head-Technical Operations
Andreas Eugen Busch Chief Scientific Officer
Amitabh Singh Director
Susan O’Reilly Secretary & Director
Sector and Competitors
1st jan.Capitalization (M$)
SHIRE0.00%0
JOHNSON & JOHNSON0.38%342 221
ROCHE HOLDING LTD.12.28%240 139
MERCK AND COMPANY7.98%211 257
PFIZER-16.38%201 883
NOVARTIS16.65%198 222